Home›Companies›Biotech & Pharma›Entopsis

Entopsis, Inc.

Updated Oct 29, 2026·Latest SEC filing Oct 19, 2023·Suggest an edit

About Entopsis

Entopsis is a private company based in Medley, Florida. It has reported $1,865,000 raised in four offerings on Form D since March 2015.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetOct 19, 2023$0of $6.0M target0—EquityRule 506(b)Form D ↗
Feb 19, 2021Mar 1, 2021$1,040,000of $6.0M target9$115KEquityRule 506(b)Form D ↗
Dec 14, 2016Jan 10, 2017$250,000of $1.0M target2$125KOptionsRule 506(c)Form D ↗
Sep 30, 2014Mar 19, 2015$575,000fully sold5$115KConvertible Promissory Note05, Rule 506(b)Form D ↗
Total, four offerings$1,865,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Entopsis's Form D filed Oct 19, 2023.

RB
Rohit Bawa
Executive officer
OP
Obdulio Piloto
Executive officer and director
CH
Chun Yi George Huang
CFO, Treas. & Sec, director
PS
Pratik Sharma
Executive officer
IC
Ian Cheong
Executive officer and director

Earlier filings also listed George Huang (executive officer, last listed Jan 2017) and Leonard Nannarone (general counsel, last listed Mar 2015).

Sources

  1. SECEntopsis, Inc. filing history